Monitoring Agency Report

October 16, 2026 To, To, The Manager, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Limited, Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai – 400 001. Mumbai – 400 051. BSE Scrip Code: 540776 NSE Symbol: 5PAISA Subject: Monitoring Agency Report for the quarter ended September 30, 2026 Dear Sir / Madam, Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 82(4) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, kindly find enclosed herewith the Monitoring Agency Report issued by CARE Ratings Limited in respect of utilization of funds raised through the Rights Issue of equity shares for the quarter ended September 30, 2026. Further, we confirm that the proceeds of the Rights Issue have been fully utilized in accordance with the objects stated in the Letter of Offer dated March 12, 2026, and that there has been no deviation in the utilization of such proceeds. Kindly take the above on record and oblige. Thanking You, For 5paisa Capital Limited Mehul Somaiya Company Secretary and Compliance Officer ACS – 43026 Email: csteam@5paisa.com Place: Thane Encl: as above 5paisa Capital Limited Registered Office: IIFL House, Sun Infotech Park, Road No.16V, Plot No. B-23, Wagle Estate, Thane - 400604 Tel.: +91 22 41035000 I E-mail: support@5paisa.com I Website: www.5paisa.com I CIN: L67190MH2007PLC289249 Monitoring Agency Report No. CARE/HO/GEN/2026-27/1165 The Board of Directors 5Paisa Capital Limited IIFL House, Sun Infotech Park, Road No. 16V, B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane – 400604, Maharashtra, India. October 15, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the Rights issue of 5Paisa Capital Limited (“the Company”) We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 468.82 crore (Gross proceeds) of the Company and refer to our duties cast under 82 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated February 27, 2026. Request you to kindly take the same on records. Thanking you, Yours faithfully, Shaik Saleem Associate Director Shaik.saleem@careedge.in Monitoring Agency Report Report of the Monitoring Agency Name of the issuer: 5Paisa Capital Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: NIL (b) Range of Deviation: Not applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Shaik Saleem Associate Director 1) Issuer Details: Name of the issuer : 5Paisa Capital Limited Name of the promoter : Mr. Nirmal Jain and Mr. R Venkataraman Industry/sector to which it belongs : Stockbroking and allied 2) Issue Details Issue Period : March 27, 2026, to April 10, 2026 Type of issue (public/rights) : Rights Issue Type of specified securities : Equity shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 468.82 crores (Gross proceeds) 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments of Source of information / certifications Comments of the the Particulars Reply considered by Monitoring Agency for Monitoring Agency Board of preparation of report Directors • CA certificate*, Bank statements, Utilization during Whether all utilization is as per the disclosures in the Offer Management certificate, FD receipts, Utilization during Q2FY27 is as per the Q2FY27 is as per Document? Exchange collateral file, Balance offer document. the offer confirmation and Banker confirmation. document. Whether shareholder approval has been obtained in case of material deviations# from expenditures disclosed in the Not applicable • Management certificate. No comments Not applicable Offer Document? Whether the means of finance for the disclosed objects of No • Management certificate. No comments No the issue have changed? Is there any major deviation observed over the earlier • Management certificate and earlier MA No deviation over the earlier MA No Not applicable monitoring agency reports? report report. Whether all Government/statutory approvals related to the Not applicable • Management certificate. No comments Not applicable object(s) have been obtained? Whether all arrangements pertaining to technical Not applicable • Management certificate. No comments Not applicable assistance/collaboration are in operation? Are there any favorable/unfavorable events affecting the There have not been any such events No • Management certificate. No viability of these object(s)? so far. Is there any other relevant information that may No • Management certificate. No comments No materially affect the decision making of the investors? * Chartered Accountant Certificate dated October 14, 2026, from M/s. V. Shankar Aiyar & Co. (FRN 109208W). #Where material deviation may be defined to mean: a) Deviation in the objects or purposes for which the funds have been raised b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents. 4) Details of objects to be monitored: (i) Cost of objects – Comments of the Board of Directors Source of information / Original cost Comments Particulars of Sr. Item certifications considered (as per the Offer Revised Cost of the Reason for Proposed -firm No Head by Monitoring Agency Document) in Rs. in Rs. Crore Monitoring cost financing option arrangements for preparation of report Crore Agency revision made Augmenting funds for 1 maintenance of [Showing first 8,000 characters — download PDF for full document]